Literature DB >> 19700396

The PREM score: a graphical tool for predicting survival in very preterm births.

T J Cole1, E Hey, S Richmond.   

Abstract

OBJECTIVE: To develop a tool for predicting survival to term in babies born more than 8 weeks early using only information available at or before birth.
DESIGN: 1456 non-malformed very preterm babies of 22-31 weeks' gestation born in 2000-3 in the north of England and 3382 births of 23-31 weeks born in 2000-4 in Trent. OUTCOME: Survival to term, predicted from information available at birth, and at the onset of labour or delivery.
METHOD: Development of a logistic regression model (the prematurity risk evaluation measure or PREM score) based on gestation, birth weight for gestation and base deficit from umbilical cord blood.
RESULTS: Gestation was by far the most powerful predictor of survival to term, and as few as 5 extra days can double the chance of survival. Weight for gestation also had a powerful but non-linear effect on survival, with weight between the median and 85th centile predicting the highest survival. Using this information survival can be predicted almost as accurately before birth as after, although base deficit further improves the prediction. A simple graph is described that shows how the two main variables gestation and weight for gestation interact to predict the chance of survival.
CONCLUSION: The PREM score can be used to predict the chance of survival at or before birth almost as accurately as existing measures influenced by post-delivery condition, to balance risk at entry into a controlled trial and to adjust for differences in "case mix" when assessing the quality of perinatal care.

Mesh:

Year:  2009        PMID: 19700396     DOI: 10.1136/adc.2009.164533

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  7 in total

1.  Counselling and management for anticipated extremely preterm birth.

Authors:  Ann L Jefferies; Haresh Kirpalani; Susan G Albersheim; Andrew Lynk
Journal:  Paediatr Child Health       Date:  2014-01       Impact factor: 2.253

2.  Gestational age and birthweight for risk assessment of neurodevelopmental impairment or death in extremely preterm infants.

Authors:  Ariel A Salas; Waldemar A Carlo; Namasivayam Ambalavanan; Tracy L Nolen; Barbara J Stoll; Abhik Das; Rosemary D Higgins
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2016-02-19       Impact factor: 5.747

3.  Predicting risk of severe neonatal outcomes in preterm infants born from mother with prelabor rupture of membranes.

Authors:  Lu Zhuang; Zhan-Kui Li; Yuan-Fang Zhu; Rong Ju; Shao-Dong Hua; Chun-Zhi Yu; Xing Li; Yan-Ping Zhang; Lei Li; Yan Yu; Wen Zeng; Jie Cui; Xin-Yu Chen; Jing-Ya Peng; Ting Li; Zhi-Chun Feng
Journal:  BMC Pregnancy Childbirth       Date:  2022-07-04       Impact factor: 3.105

Review 4.  Prediction of mortality in very premature infants: a systematic review of prediction models.

Authors:  Stephanie Medlock; Anita C J Ravelli; Pieter Tamminga; Ben W M Mol; Ameen Abu-Hanna
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

5.  Swiss medical centres vary significantly when it comes to outcomes of neonates with a very low gestational age.

Authors:  Martina A Steurer; Mark Adams; Peter Bacchetti; Sven M Schulzke; Matthias Roth-Kleiner; Thomas M Berger
Journal:  Acta Paediatr       Date:  2015-06-24       Impact factor: 2.299

6.  Comparing very low birth weight versus very low gestation cohort methods for outcome analysis of high risk preterm infants.

Authors:  Louise Im Koller-Smith; Prakesh S Shah; Xiang Y Ye; Gunnar Sjörs; Yueping A Wang; Sharon S W Chow; Brian A Darlow; Shoo K Lee; Stellan Håkanson; Kei Lui
Journal:  BMC Pediatr       Date:  2017-07-14       Impact factor: 2.125

7.  Study protocol for a randomised controlled trial: treatment of early intrauterine growth restriction with low molecular weight heparin (TRACIP).

Authors:  Edurne Mazarico; Anna Peguero; Marta Camprubí; Carlota Rovira; Maria Dolores Gomez Roig; Daniel Oros; Patricia Ibáñez-Burillo; Jon Schoorlemmer; Narcís Masoller; Maria Dolors Tàssies; Francesc Figueras
Journal:  BMJ Open       Date:  2018-10-23       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.